CD19 and breast cancer: Although the percentage and absolute number of CD19+CD24+CD38+ B cells in the PD-L1hi BC group were higher than those in the control group under IDR culture condition, no significant difference was observed between the PD-L1hi BC group and the control group (P = 0.268 and P = 0.269, respectively; Figure 5B).